Laurus Labs gets license to manufacture, market 2-Deoxy-D-Glucose in India

02 Jul 2021 Evaluate

Laurus Labs has received the licence from Defence Research & Development Organisation (DRDO) to manufacture and market of 2- Deoxy-D-Glucose (2DG). 2DG has been given emergency approval by the Drug Controller General of India (DCGI) for use on COVID-19 patients in the country.

Laurus Labs has already applied with CDSCO for emergency use authroisation (EUA) for 2DG. 

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

1040.35 3.05 (0.29%)
11-Mar-2026 15:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1822.20
Dr. Reddys Lab 1326.50
Cipla 1328.20
Zydus Lifesciences 921.70
Lupin 2339.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×